Skye Hydration

Acquiring Nekta Nutrition · Regulation CF Offering

$500,000

Minimum Offering

$100

Minimum Investment

$100 / Unit

Class B Common Membership Units

$2,000,000

Maximum Offering

Preferred Unit

Membership Unit Class

4-Year Term

Investment Term

8%

Cumulative Preferred Unit Dividend

Review the Texture Capital risk disclosures

Target Close — TBD
Approved:
Pending:
Closed:

The gut health drinks market alone is $30B+ and expanding rapidly as consumers seek beverages with functional benefits.

Asia-Pacific is the fastest-growing region for functional beverages, driven by health-conscious consumers and rising disposable income. Functional beverages are projected to outpace traditional soft drinks in the next decade. Nekta's existing distribution across New Zealand, Australia, Hong Kong, Macau, and the Pacific Islands positions Skye to scale into these high-growth markets.

Target Demographics

Health & Wellness Lifestyle

Gut Health & Digestion-Focused

Mid to Higher Income

Ages 25–65

Asia-Pacific & Australia Primary Markets

Business Structure

Skye + Nekta: A Platform Model

Skye Hydration LLC

U.S. operating parent (Delaware LLC). Holds IP and strategic direction for the platform.

Nekta Nutrition Limited

New Zealand operating business. Acquired debt-free at close. 32 years of kiwifruit beverage heritage.

Skye Nekta Limited

100% Skye-owned NZ subsidiary. IP and trademarks transfer at/around close.

Nekta Nutrition

Product & Business Proof

Founded 1994

32 years of New Zealand kiwifruit beverage heritage and operational discipline.

NZD ~$3M Annual Revenue

Established revenue base with room for growth through distribution expansion.

95%+ NZ Major Grocery Placement

Strong shelf presence across New Zealand's largest grocery chains.

40+ Developed SKUs

Extensive product pipeline including gut health, reduced sugar, and aloe vera variants.

20% Capacity Utilization

Significant headroom to scale production without major capital investment.

14–16% Gross Margin

Healthy margins with opportunities for improvement through operational optimization.

Near Breakeven / Adjusted Net Loss

Efficient cost structure with modest investment needed to reach profitability.

Distribution

Existing Markets

Market Notes
New Zealand 95%+ major grocery placement. 32 years of shelf presence.
Australia Established distribution with room for expansion into unserved stores.
Hong Kong Strategic Asia-Pacific gateway market.
Macau Regional distribution presence.
Pacific Islands Island-wide retail and specialty distribution.
Taiwan (Planned) Target expansion market pending close.

Acquisition Terms

Nekta Nutrition Acquisition

Term Details
Total Purchase Price $1,000,000 USD
Deposit Paid $50,000 USD (already paid)
Due at Close $700,000 USD
Deferred Payment $250,000 USD
Interest on Deferred 5% simple interest
Seller Advisory 12-month seller advisory period
Escrow 20% of purchase price held in escrow
Target Close Pending — subject to customary closing conditions

Growth Strategy

Three-Year Roadmap

Year 1

  • Close Nekta acquisition and integrate operations
  • Stabilize and optimize existing distribution
  • Launch in-store sampling and point-of-purchase displays
  • Begin margin improvement initiatives

Year 2

  • Expand into New Zealand convenience stores
  • Scale distribution across unserved Australian stores
  • Test Skye canned water alongside Nekta products
  • Evaluate additional functional beverage brands for acquisition

Year 3

  • Prepare for U.S. expansion
  • Launch pipeline SKUs from Nekta's 40+ developed products
  • Build brand awareness through strategic partnerships
  • Optimize supply chain and production efficiency

Cross-Cutting Themes

Margin optimization · Distribution expansion · U.S. runway preparation · Operational excellence

Our Plan

Use of Proceeds

At Skye Hydration, we aim to allocate the Regulation CF proceeds to maximize impact and strategic growth.

The majority of funds will be used to close the Nekta acquisition and provide working capital to scale the combined business.

We are allocating funds across acquisition close, working capital, marketing, and offering costs.

The breakdown reflects our priority of securing the acquisition while building the infrastructure to grow.

$700,000 - Acquisition close payment (70% of total offering)

$560,000 - Working capital and operations (28% of total offering)

$340,000 - Marketing and brand building (17% of total offering)

$200,000 - Offering costs and intermediary fees (10% of total offering)

$200,000 - Deferred purchase reserve (10% of total offering)

Skye Hydration is currently selling reduced concentrate alkaline water to our co-packer so they can make alkaline water for their clients. While this water differs greatly from SkyeH, we are excited to deepen our relationship with the industry.

Offering Terms

Regulation CF Offering

Term Details
Regulation Regulation Crowdfunding (Reg CF) — open to accredited and non-accredited investors
Platform Offered through Texture Capital Inc., a FINRA member broker-dealer
Offered Unit Price $100 per offered unit
Class B Common Units Common membership units representing equity in Skye Hydration LLC
Preferred Unit Preferred membership unit with 8% cumulative dividend
Dividend 8% cumulative preferred dividend, paid quarterly when declared
Term 4-year investment term
Maximum Offering $2,000,000
Minimum Offering $500,000
Minimum Investment $100
Target Close Pending — subject to customary closing conditions

Why Now

Market Timing and Opportunity

Market Timing

Functional beverages are outpacing traditional soft drinks. The gut health and wellness segments are growing rapidly, especially in Asia-Pacific.

Acquisition Opportunity

Nekta Nutrition represents a rare opportunity to acquire an established functional beverage brand with real revenue, distribution, and product pipeline at an attractive valuation.

Platform Leverage

Skye's platform model allows us to acquire and scale multiple functional beverage brands, starting with Nekta and expanding into complementary categories.

About Us

Skye Hydration is a Platform Functional Beverage Company.

Skye Hydration is a platform functional beverage company. We acquire and scale established functional beverage brands with real distribution and operational discipline. Our first acquisition is Nekta Nutrition Limited — a 32-year-old New Zealand kiwifruit beverage company.

Looking ahead, Skye plans to launch SkyeH, a hydrogen-rich alkaline drinking water, as the future flagship product of the platform. SkyeH will be bottled in a beautiful, resealable, reusable, and recyclable aluminum bottle, designed to meet customer demand in the enhanced water category.

We believe that combining Nekta's existing business with Skye's platform approach — backed by extensive connections in big-box and c-store space and deep category expertise — will drive growth across both legacy and new products.

Skye Hydration has signed a definitive agreement to acquire Nekta Nutrition Limited — a 32-year-old New Zealand functional beverage company with distribution across New Zealand, Australia, Hong Kong, Macau, and the Pacific Islands. Pending close.

The Team

Who's Building This

Joe founded Skye Hydration in 2023 and is leading the platform build and the pending Nekta acquisition. Joe has 13 years' experience in the water and beverage industry and 30+ years as an entrepreneur in multiple industries.

Joseph M. Stapley

CEO & Founder
Founder & Board Member with 35+ years of experience in investment banking and real estate development, currently working on a 70-acre resort in the Turks & Caicos. Graduate of UC Berkeley in Economics.

Sean L. Sullivan

Board Member & Founder

Frequently Asked Questions

Reg CF or Regulation Crowdfunding allows companies to offer and sell up to $5 million of their securities without registering with the SEC. Crowdfunding involves raising money through small individual investments from a large number of people. With Reg CF, the general public can participate in early capital raising for start-ups and early-stage businesses.

Yes, anyone can invest in a Regulation Crowdfunding offering. However, due to the risks involved, there are limits on how much you can invest within any 12-month period based on your net worth and annual income.

If you are a non-accredited investor, your investment limit depends on your net worth and annual income:

  • If either your annual income or net worth is less than $124,000, you can invest up to the greater of either $2,500 or 5% of the greater of your annual income or net worth.
  • If both your annual income and net worth are $124,000 or more, you can invest up to 10% of your annual income or net worth, whichever is greater, but not to exceed $124,000.

An individual is considered an accredited investor if they meet one of the following criteria:

  • Earned income exceeding $200,000 (or $300,000 together with a spouse) in each of the prior two years and expects the same for the current year.
  • Has a net worth over $1 million, either alone or with a spouse, excluding the value of their primary residence and any loans secured by it.
  • Holds certain professional certifications, designations, or credentials in good standing, including a Series 7, 65, or 82 license.

Texture Capital Inc. is a FINRA Member broker-dealer engaged to act as an onboarding agent for this offering. We conduct Know Your Customer (KYC), Identification, and Anti-Money Laundering (AML) checks on all investors. We also perform due diligence on the issuer to ensure they are a registered business in good standing and that the principals are not considered Bad Actors. For more details on Texture Capital’s services, please consult our Form CRS (Customer Relationship Summary).

Skye Hydration has signed a definitive agreement to acquire Nekta Nutrition Limited — a 32-year-old New Zealand functional beverage company. Nekta has 5 active SKUs in market, 40+ developed products in its pipeline, and distribution across New Zealand, Australia, Hong Kong, Macau, and the Pacific Islands. The acquisition is pending close and subject to customary closing conditions.

Nekta’s existing New Zealand operating team continues post-close, bringing more than three decades of category and supply-chain expertise to the combined business. Skye will invest in marketing, distribution expansion, and product development to scale Nekta’s existing business while preparing for future Skye^H product launches.

Skye^H, Skye’s hydrogen-rich alkaline drinking water, is planned as a future flagship product. The timing of the Skye^H launch is not guaranteed and will depend on the successful close of the Nekta acquisition, market conditions, and execution of the platform strategy. Initial testing alongside Nekta products is planned for Year 2–3.

The Form C is available through the Texture Capital investment platform at /invest. The Form C contains detailed financial information, risk factors, and the complete offering memorandum.

Crowdfunding securities offerings are not registered with the SEC and are highly speculative. For a comprehensive discussion of the risk factors, please refer to the Risks section of this page and the Form C.

For questions about the investment application and process, please contact onboarding@texture.capital or call +1 646 979 8558 and select option 9.

Prospective investors with questions about the company or its product or the offering should submit their questions in the Discussion section of the investment website. This is a public forum where valid questions will be displayed for all to view, with responses clearly tagged with the responder’s identity.

Risks

Investment Risks

Investing in Regulation CF offerings involves substantial risk. The following risks are not exhaustive, and investors should review the Form C for a complete discussion of risk factors.

Risk Description
Pre-Revenue Skye Entity Skye Hydration LLC is a pre-revenue entity. The acquisition of Nekta Nutrition is the primary path to revenue. The acquisition may not close as planned.
Deal Contingency The Nekta acquisition is subject to customary closing conditions. If the acquisition does not close, Skye's business model will change materially.
Operating Risk Nekta's operations may not scale as projected. Competition, supply chain disruptions, or operational challenges could impact growth.
Geographic Concentration Nekta's revenue is concentrated in New Zealand and Australia. Economic or regulatory changes in these markets could materially impact the business.
Skye Water Timing The launch of Skye^H hydrogen-rich alkaline water is not guaranteed. Timing, market acceptance, and execution risks apply.
Category Competition The functional beverage category is competitive. Larger competitors may have greater resources and brand recognition.
Illiquidity Securities offered under Regulation CF are illiquid. There is no guaranteed secondary market or liquidity event.
No Promised Liquidity Event There is no guarantee of an acquisition, IPO, or other liquidity event. Investors may not be able to sell their securities.